O propósito do presente estudo foi avaliar o comportamento de células pulpares humanas expostas ao TGFβ1 e ao aFGF, em cultura, nas seguintes concentrações: TGFβ1 a 1ng/mL, TGFβ1 a 5ng/mL, TGFβ1 a 1ng/mL + aFGF a 5ng/mL, TGFβ1 a 5ng/mL + aFGF a 5ng/mL e aFGF a 5ng/mL. Foi avaliada a morfologia celular, a atividade da fosfatase alcalina, através de ensaio com pNPP como substrato e a expressão das proteínas osteocalcina, sialoproteína óssea e sialofosfoproteína de dentina, através de RT-PCR. Após quatro dias, verificou-se que a média do número de nucléolos no grupo tratado com TGFβ1 a 1ng/mL foi significativamente maior que no grupo tratado com aFGF a 5ng/mL. A média da atividade da fosfatase alcalina no grupo tratado com TGFβ1 a 1ng/mL foi significativamente maior que no grupo tratado com TGFβ1 a 5ng/mL + aFGF a 5ng/mL. Foi observada a expressão de osteocalcina em todas as células pulpares humanas que proliferaram em cultura. Entretanto, no grupo em que foi utilizado o aFGF a 5ng/mL houve diminuição da expressão da osteocalcina. A exposição dos fatores não induziu a expressão de componentes da matriz de dentina tais como BSP e DSPP. Sugere-se que as células expostas ao TGFβ1 1ng/mL foram estimuladas, apresentando uma maior atividade celular e as células expostas ao aFGF 5ng/mL foram inibidas, apresentando uma menor atividade celular. / The aim of the present work was to evaluate the behavior of human dental pulp cells exposed to TGFβ1 and aFGF in culture, at the following concentrations: TGFβ1 1ng/mL, TGFβ1 5ng/mL, TGFβ1 1ng/mL + aFGF 5ng/mL, TGFβ1 5ng/mL + aFGF 5ng/mL e aFGF 5ng/mL. We assessed the cellular morphology, alkaline phosphatase activity, using pNPP as substrate, and expression of osteocalcin, bone sialoprotein, dentin sialophosphoprotein proteins by RT-PCR. After four days, the nucleolus media in the group treated with TGFβ1 1ng/mL was significantly higher than the group treated with aFGF 5ng/mL The alkaline phosphatase activity in the TGFβ1 1ng/mL treated group was significantly higher than the media observed in TGFβ1 5ng/mL + aFGF 5ng/m treated group. Osteocalcin expression was observed in all human dental pulp cell cultures. However, in the aFGF 5ng/mL treated group the osteocalcin expression decreased. The exposure to growth factors did not induced the expression of dentin matrix components such as BSP or DSPP. Our data suggest that the cells exposed to TGFβ1 1ng/mL were stimulated and had a higher cell activity, and that cells exposed to aFGF 5ng/mL were inhibited having a cell activity decrease.

O propósito do presente estudo foi avaliar o comportamento de células pulpares humanas expostas ao TGFβ1 e ao aFGF, em cultura, nas seguintes concentrações: TGFβ1 a 1ng/mL, TGFβ1 a 5ng/mL, TGFβ1 a 1ng/mL + aFGF a 5ng/mL, TGFβ1 a 5ng/mL + aFGF a 5ng/mL e aFGF a 5ng/mL. Foi avaliada a morfologia celular, a atividade da fosfatase alcalina, através de ensaio com pNPP como substrato e a expressão das proteínas osteocalcina, sialoproteína óssea e sialofosfoproteína de dentina, através de RT-PCR. Após quatro dias, verificou-se que a média do número de nucléolos no grupo tratado com TGFβ1 a 1ng/mL foi significativamente maior que no grupo tratado com aFGF a 5ng/mL. A média da atividade da fosfatase alcalina no grupo tratado com TGFβ1 a 1ng/mL foi significativamente maior que no grupo tratado com TGFβ1 a 5ng/mL + aFGF a 5ng/mL. Foi observada a expressão de osteocalcina em todas as células pulpares humanas que proliferaram em cultura. Entretanto, no grupo em que foi utilizado o aFGF a 5ng/mL houve diminuição da expressão da osteocalcina. A exposição dos fatores não induziu a expressão de componentes da matriz de dentina tais como BSP e DSPP. Sugere-se que as células expostas ao TGFβ1 1ng/mL foram estimuladas, apresentando uma maior atividade celular e as células expostas ao aFGF 5ng/mL foram inibidas, apresentando uma menor atividade celular. / The aim of the present work was to evaluate the behavior of human dental pulp cells exposed to TGFβ1 and aFGF in culture, at the following concentrations: TGFβ1 1ng/mL, TGFβ1 5ng/mL, TGFβ1 1ng/mL + aFGF 5ng/mL, TGFβ1 5ng/mL + aFGF 5ng/mL e aFGF 5ng/mL. We assessed the cellular morphology, alkaline phosphatase activity, using pNPP as substrate, and expression of osteocalcin, bone sialoprotein, dentin sialophosphoprotein proteins by RT-PCR. After four days, the nucleolus media in the group treated with TGFβ1 1ng/mL was significantly higher than the group treated with aFGF 5ng/mL The alkaline phosphatase activity in the TGFβ1 1ng/mL treated group was significantly higher than the media observed in TGFβ1 5ng/mL + aFGF 5ng/m treated group. Osteocalcin expression was observed in all human dental pulp cell cultures. However, in the aFGF 5ng/mL treated group the osteocalcin expression decreased. The exposure to growth factors did not induced the expression of dentin matrix components such as BSP or DSPP. Our data suggest that the cells exposed to TGFβ1 1ng/mL were stimulated and had a higher cell activity, and that cells exposed to aFGF 5ng/mL were inhibited having a cell activity decrease.

O propósito do presente estudo foi avaliar o comportamento de células pulpares humanas expostas ao TGFβ1 e ao aFGF, em cultura, nas seguintes concentrações: TGFβ1 a 1ng/mL, TGFβ1 a 5ng/mL, TGFβ1 a 1ng/mL + aFGF a 5ng/mL, TGFβ1 a 5ng/mL + aFGF a 5ng/mL e aFGF a 5ng/mL. Foi avaliada a morfologia celular, a atividade da fosfatase alcalina, através de ensaio com pNPP como substrato e a expressão das proteínas osteocalcina, sialoproteína óssea e sialofosfoproteína de dentina, através de RT-PCR. Após quatro dias, verificou-se que a média do número de nucléolos no grupo tratado com TGFβ1 a 1ng/mL foi significativamente maior que no grupo tratado com aFGF a 5ng/mL. A média da atividade da fosfatase alcalina no grupo tratado com TGFβ1 a 1ng/mL foi significativamente maior que no grupo tratado com TGFβ1 a 5ng/mL + aFGF a 5ng/mL. Foi observada a expressão de osteocalcina em todas as células pulpares humanas que proliferaram em cultura. Entretanto, no grupo em que foi utilizado o aFGF a 5ng/mL houve diminuição da expressão da osteocalcina. A exposição dos fatores não induziu a expressão de componentes da matriz de dentina tais como BSP e DSPP. Sugere-se que as células expostas ao TGFβ1 1ng/mL foram estimuladas, apresentando uma maior atividade celular e as células expostas ao aFGF 5ng/mL foram inibidas, apresentando uma menor atividade celular. / The aim of the present work was to evaluate the behavior of human dental pulp cells exposed to TGFβ1 and aFGF in culture, at the following concentrations: TGFβ1 1ng/mL, TGFβ1 5ng/mL, TGFβ1 1ng/mL + aFGF 5ng/mL, TGFβ1 5ng/mL + aFGF 5ng/mL e aFGF 5ng/mL. We assessed the cellular morphology, alkaline phosphatase activity, using pNPP as substrate, and expression of osteocalcin, bone sialoprotein, dentin sialophosphoprotein proteins by RT-PCR. After four days, the nucleolus media in the group treated with TGFβ1 1ng/mL was significantly higher than the group treated with aFGF 5ng/mL The alkaline phosphatase activity in the TGFβ1 1ng/mL treated group was significantly higher than the media observed in TGFβ1 5ng/mL + aFGF 5ng/m treated group. Osteocalcin expression was observed in all human dental pulp cell cultures. However, in the aFGF 5ng/mL treated group the osteocalcin expression decreased. The exposure to growth factors did not induced the expression of dentin matrix components such as BSP or DSPP. Our data suggest that the cells exposed to TGFβ1 1ng/mL were stimulated and had a higher cell activity, and that cells exposed to aFGF 5ng/mL were inhibited having a cell activity decrease.

Made available in DSpace on 2014-07-29T15:21:58Z (GMT). No. of bitstreams: 1 Dissertacao parte1 Larissa Santana Arantes Elias.pdf: 1237563 bytes, checksum: 572e0535bd8ddf8a3d9cd5c693a6aa5f (MD5) Previous issue date: 2010-03-19 / The RANK (receptor activator of nuclear factor Kappa-Beta)-RANKL (receptor activator of nuclear factor-kappa beta ligand)-OPG (osteoprotegerin) system is the principal means of differentiating and activating osteoclasts. Changes along this path have been associated with various bone related lesions (BRL), whether benign or malignant, such as osteosarcoma (OS). This system induces resorption when it is deregulated, and in the case of LROs, by replacing the bone tissue for fibrous tissue with the presence of various forms of ossification. And in this same context another protein, osteocalcin (OC), a marker of late ossification, plays a key role in the diagnosis of these lesions. This being so, the objective of this study was to identify, quantify and compare cell RANK+, RANKL+, OPG+ and OC+ in lesions of the jaw with bone involvement: ossifying fibroma (OF), fibrous dysplasia (FD), simple bone cysts (SBC), central giant cell lesions (CGCL) and osteosarcoma (OS) so as to contribute to understanding the pathogenesis and establishing the diagnosis of these lesions. RANK+, RANKL+, OPG+ and OC+ cells were identified by the technique of immunohistochemistry, a method of immunoperoxidase and polymer, in 10 samples of OF, FD, SBC, CGCL and 5 samples of OS. Our results showed that all samples were positive for RANK, RANKL, OPG and OC. In the stromal fibroblast-like cells, the OF (P<0.001), CGCL (P=0.007) and OS (P=0,058) presented a greater expression of RANKL than OPG, in contrast with both the SBC (P=0.003) and the FD (P<0.001). As for bone-matrix (cells around bone/osteoid-osteoblast and osteoclast), the OS (P=0.24) and OF (P=0.001) samples demonstrated a higher RANKL immunoreactivity and and a lower in FD (P=0.001) and SBC (P=0.4) samples. In terms of OC, a higher expression was shown in FD, SBC, and OS (P=0.008). Our results suggest that OF, CGCL and OS express bone metabolism regulators, which may be related to increased bone resorption in these lesions. In addition, osteoblastic involvement was seen in FD and OS. Note: The superscript + is where it appears. Programs to copy some formatting errors. / O sistema RANK (receptor activator of nuclear factor Kappa-Beta)-RANKL (receptor activator of nuclear factor-kappa beta ligand)-OPG (osteoprotegerin) constitui uma das principais vias de diferenciação e ativação dos osteoclastos e alterações nessa via tem sido associadas a diversas lesões relacionadas ao osso (LRO), benignas e maligna como no osteossarcoma (OS). Esse sistema quando desregulado induz reabsorção, e no caso das LROs, através da substituição do tecido ósseo por um tecido fibroso com a presença de várias formas de ossificação. E nesse contexto outra proteína, a osteocalcina (OC), que é um marcador tardio de ossificação, desempenha um papel fundamental no diagnóstico destas lesões. Portanto, o objetivo do presente estudo foi identificar, quantificar e comparar células RANK+, RANKL+, OPG+ e OC+ em lesões dos maxilares com envolvimento ósseo: fibroma ossificante (FO), displasia fibrosa (DF), cisto ósseo simples (COS), lesão central de células gigantes (LCCG) e osteossarcoma (OS). As células RANK+, RANKL+, OPG+ e OC+ foram identificadas pela técnica da imunoistoquímica, método da imunoperoxidase e do polímero, em 10 amostras de FO, DF, COS, LCCG e 5 amostras de OS. Quando comparado as lesões entre si, tanto nas células fibroblásticas estromais quanto da matriz óssea, nossos resultados demonstraram que os ativadores da reabsorção óssea (RANK/RANKL) apresentam uma maior expressão no FO e LCCG e, o inibidor da reabsorção (OPG) e a OC apresentaram maior na DF e COS. Em adição, nossos achados revelam que o OS apresenta alta expressão de todas as proteínas avaliadas, quando comparadas àquelas das LROs. Todavia, uma maior expressão de RANKL em relação à OPG e OC foi evidenciada nesta neoplasia. Nossos resultados sugerem que o FO, a LCCG e o OS expressam reguladores do metabolismo ósseo que podem estar relacionados com a reabsorção óssea aumentada nessas lesões, sendo que na DF e no OS foi observado envolvimento osteoblástico. OBS: A + está sobrescrita onde aparece. Programas copiam com erros certas formatações.

INTRODUÇÃO: O hipoestrogenismo pode determinar perda da massa mineral óssea, diminuindo a qualidade do osso. Assim, vários fármacos são ministrados para evitar esta perda, porém, podem determinar efeitos colaterais importantes. Portanto, questiona-se se o emprego do estrogênio associado a estas substâncias poderia minimizar os efeitos adversos e manteria a massa mineral óssea. Contudo, há poucas informações sobre os efeitos destas combinações. Esta pesquisa tem como objetivo avaliar a ação do estrogênio, raloxifeno e do extrato de soja rico em gensteína, isolado ou combinado no osso de ratas ovariectomizadas. MATERIAIS E MÉTODOS: No nono dia de nascimento, todas as ratas receberam propionato de testosterona (0,1 g/g). No sexto mês de idade, os animais do controle fisiológico foram identificados como GI e receberam apenas o veículo (propilenoglicol em 0,5 ml/dia) durante o experimento e os outros que receberam testosterona foram ovariectomizados e divididos aleatoriamente em seis grupos: GII veículo (controle castrado, n=6); GIII - estrogênio conjugados eqüinos (ECE, (50 g/Kg/dia, n=8); GIV raloxifeno (RAL, 0,75 mg/kg/dia, n=8); GV extrato de soja enriquecido com genisteína (ESG, 300 mg/kg/dia, n=7); GVI ECE + ESG (50 g/Kg/dia + 300 mg/kg/dia, n=7); GVII - ECE+RAL (50 g/Kg/dia + 0,75mg/kg/dia, n=6). Após três meses da cirurgia, os fármacos foram ministrados por 120 dias consecutivos. Posteriormente, os animais foram sacrificados sob anestesia, sendo retirada a tíbia esquerda para rotina histológica. Os cortes histológicos foram corados pela hematoxilina-eosina para avaliar a microarquitetura óssea. Foram feitos procedimentos imunoistoquímicos, de imunofluorescência e PCR para quantificar as principais proteínas ósseas estruturais (colágeno tipo I, osteocalcina, osteopontina e osteoprotegerina), bem como de seus respectivos RNA mensageiros. Os dados foram analisados pelos testes de ANOVA e Tukey. RESULTADOS: Todos os tratamentos determinaram aumento da quantidade de osso trabecular (p<0,05). As fibras totais de colágeno apresentaram-se aumentadas em todos os grupos tratados, exceto com o raloxifeno. Já as fibras finas de colágeno diminuíram apenas no grupo tratado com estrogênio. As frações de colágeno tipo I, mostraram-se aumentadas nos grupos tratados com estrogênio e sua asssociação com o raloxifeno. O colágeno tipo III esteve aumentado no grupo tratado com estrogênio em associação com extrato de soja rico em genisteína. Em relação às proteínas não colagenosas, a osteoprotegerina apresentou-se aumentada nos grupos tratados com estrogênio, suas associações e com o extrato de soja rico em genisteína. A osteopontina esteve diminuída em todos os grupos tratados e a osteocalcina mostrou-se aumentada apenas no grupo tratado com ralolxifeno, em comparação ao grupo castrado (p<0,05). Não houve diferença estatística significante do PCR em tempo real na análise dos transcritos entre os grupos estudados. CONCLUSÃO: A combinação de estrogênio com raloxifeno ou extrato de soja rico em genisteína não trouxe benefícios adicionais na qualidade do tecido ósseo, como ocorreu com esses fármacos isoladamente / INTRODUCTION: Hypoestrogenism can determine bone mineral loss, resulting in decreased bone quality. To prevent that process, several drugs are administered, which can lead, however, to important side effects. Therefore, it is questionable whether the use of estrogen associated with those substances could minimize the adverse effects and maintain bone mineral mass. There is little information on the effects of those compounds. This research aims to evaluate the action of unopposed estrogen or combined with raloxifene and genistein-rich soy extract on ovariectomized adult female rats. MATERIALS AND METHODS: On the ninth day of birth, rats received, testosterone propionate (0.1 mg / g). On the sixth month, animals in the physiological control were identified as GI and received only the vehicle (propylene glycol at 0.5 ml / day) during the experiment and the other which was administered testosterone underwent ovariectomy and divided randomly into six groups: GII - vehicle (control castrated, n = 6); GIII - conjugated equine estrogen (CEE, 50 mg / kg / day, n = 8); GIV - raloxifene (RAL, 0.75 mg / kg / day, n = 8) ; GV - soy extract enriched with genistein (ESG, 300 mg / kg / day, n = 7), GVI - ECE + ESG (50 mg / kg / day + 300 mg / kg / day, n = 7); GVII - ECE + RAL (50 mg / kg / day + 0.75mg/kg/day, n = 6).Three months after the surgery, drugs were consecutively administered for 120 days. Subsequently, the animals were sacrificed on anesthesia and their left tibiae were removed for routine histology. The histological sections were stained by hematoxylin-eosin to evaluate bone microarchitecture. Immunohistochemical, immunofluorescence and PCR procedures were performed to quantify the main structural bone proteins (type I collagen, osteocalcin, osteopontin, and osteoprotegerin) as well as their mRNA. The data were analyzed by ANOVA and Tukey test. RESULTS: All treatments led to increased amounts of trabecular bone (p <0.05). The total collagen fibers had to be enlarged in all treated groups, except with raloxifene. Already thin collagen fibers decreased only in the group treated with estrogen. The fractions of type I collagen, were increased in groups treated with estrogen and its asssociação with raloxifene. Type III collagen was increased in the group treated with estrogen in combination with soybean extract rich in genistein. Regarding the non-collagenous proteins, the increased osteoprotegerin presented in groups treated with estrogen, and their associations with soy extract rich in genistein. The osteopontin was decreased in all treated groups and osteocalcin was increased only in the treated group ralolxifeno, compared to the castrated group (p <0.05). There was no statistically significant difference from the real-time PCR analysis of transcribed between the groups. CONCLUSION: The combination of estrogen with raloxifene or genistein-rich soy extract was uncapable of bringing additional benefits to the quality of bone tissue as observed with those drugs alone

Energy homeostasis is an important physiological mechanism essential for balancingenergy flow through the living systems by managing overall metabolism in the body. Thus, energy homeostasis is under a tight control by means of extremely well-regulated energy metabolism. One of the most common metabolic disorders that occur following disruption in energy homeostasis mechanisms is obesity. Obese individuals develop insulin resistance in the peripheral tissues (fat and muscle) and may also include non-alcoholic fatty liver disease. Insulin resistance is the primary factor responsible for the development of type 2 diabetes mellitus (T2D). Towards control and management of T2D condition, insulin, drugs that regulate the insulin sensitivity and drugs that regulate glucose metabolism are widely used. Repeated insulin administration is painful, expensive and requires constant glucose monitoring while other drugs have various limitations and side effects. Therefore, there is wide scope development of new anti-diabetic molecules for effective management of T2D. Studies related to energy metabolism are necessary to understand the cause of such disorders and improve existing methods to manage metabolic abnormalities. Animal models to understand such metabolic disorders have been developed by chemical treatments and genetic modifications, but diet-induced obese (DIO) animal models appear to be the better among all the models reported. DIO animal models are known to most closely mimic the physiological situation. Apart from the experimental model system studies have been conducted under physiological conditions to gain knowledge on possible mechanisms behind energy balance maintained and established during extreme situations such as pregnancy and lactation. To support fetal growth and milk synthesis several metabolic adjustments occur during pregnancy and lactation without the major disruption in the maternal energy homeostasis. In the present study, to gain knowledge on the mother’s body glucose, lipid management and insulin responses throughout the gestation and lactation periods analyses were carried out during at different stages of pregnancy and lactation in rats. It was observed that during pregnancy, the dam developed insulin resistance in peripheral tissues with decreased activation of insulin pathway and reduced glucose utilization while the liver remained unaffected. Although, as soon as the lactation began, peripheral tissue such as muscle developed increased insulin sensitivity associated with increased expression of glucose transporter gene and higher glucose metabolism. The reversal of insulin response in the muscle tissue observed during lactation appears to be a suitable model system for understanding the process by which the body undergoes a transition from insulin resistant state to sensitive state under a physiological condition. Interestingly, early lactation period is known to have much lower levels of insulin available to act upon peripheral tissues. Factors involved in this transition could be potential therapeutic agents for control of T2D, since during early stages of T2D muscle appears to be the first metabolic organ to exhibit resistance to insulin. The undercarboxylated osteocalcin (UNOC) has been reported to function as anti-diabetic molecule. UNOC is released from skeletal system during bone turnover, especially due to resorption process. Experiments were carried out to examine the role of UNOC during the transition from insulin resistant state of pregnancy to sensitive state of lactation period. It was observed that UNOC levels were lower during pregnancy, but increased during early lactation (day 3 to 6 of lactation). The increased UNOC levels seen during early lactation was higher than the levels observed in non-pregnant, non-lactating (NPNL) rats and the UNOC levels decreased following removal of pups immediately after parturition. It was noted that altering UNOC levels during early lactation altered the insulin response of the whole body and muscle transporter-4 expression (glut4) of lactating rats. A significant increase in bone turnover was also observed during lactation compared to NPNL and pregnant rats. The data suggest that increased bone turnover leads to increased UNOC levels in blood during lactation. Estrogen is known as bone protector molecule which acts via its receptors, estrogen receptor α and β (ERα and β). It was reported that ERβ is a dominant regulator of estrogen signaling when both the receptors of estrogen i.e. ERα and ERβ coexist in the target tissue and estrogen levels are relatively higher. Compared to NPNL rats estrogen levels have shown to be higher during late pregnancy and lower during early lactation. It was observed that liver and adipose tissues largely express ERα, but the muscle showed expression of both the receptors in NPNL rats indicating that muscle is the metabolic tissue that may be modulated by both the receptors. It has been reported that ERβ suppresses ERα action on glut4 transcription in the myocytes. It is possible that the altered ERs ratio modulates glut4 expression during late pregnancy and early lactation. The receptor expression ratio data indicated that muscle is an ERβ dominant during late pregnancy, while it is ERα dominant during early lactation. Further, alteration in UNOC levels during early lactation changed ERs ratio but not sufficient enough to alter the ER dominance, indicating lack of effect of UNOC on ER dominance during early lactation. Experiments were conducted to alter insulin sensitivity during early lactation to extrapolate physiological findings to a pathological condition of the DIO model by feeding rats with high-fat diet (HFD). During early lactation, HFD dams had lower insulin response, lower circulatory UNOC level and lower UNOC receptor (GPRC6A) expression in the muscle. Gene expression of muscle glut4 was lower in HFD rats and the tissue remained ERα dominant indicating no role of HFD on ERs ratio in muscle during early lactation. UNOC has been found to have negative effect on lipid accumulation. During pregnancy, lipid accumulation is one of the first events essential for proper fetal development. Since UNOC levels were suppressed during pregnancy, experiments were carried out to examine relevance of UNOC suppression on lipid accumulation during early pregnancy. For this purpose, pharmacological approaches were utilized to alter UNOC levels during early pregnancy. It was observed that the transient elevation of UNOC levels caused decrease in maternal fat depots without changing circulatory triacylglyceride (TAG) levels. In experiments that decreased UNOC levels in NPNL state to mimic lower levels of UNOC present during early pregnancy, it was found fat storage was higher and TG was found to be lowered in the circulation. These results indicate that UNOC can cause a reduction in fat accumulation and TG levels but UNOC effects on TG levels, was not observed during pregnancy. The data taken together suggest that suppression of UNOC is required for better fat deposition in the mother’s body. Although, some studies have indicated an insulin response transition occurring during pregnancy to lactation, but the factors involved in this transition have not been reported. This report discusses about the factors such as UNOC and ERs and their involvement in the transition process. UNOC role has been studied in genetically modified models and in metabolic disorders such as obesity model system and evidence for physiological role of UNOC would further support its candidature as anti-diabetic molecule. The present research work is the first report to detail relevance of UNOC in physiological conditions such as pregnancy and lactation for glucose and lipid management.

This thesis focuses on testing and improving Ti-6Al-4V ELI biomaterials, which are currently one of the most used titanium alloys in biomedicine (predominantly in orthopaedics and dentistry), in cooperation with research institutions and private companies developing and producing such materials. The metallic samples were previously modified by plasma electrolytic oxidation (PEO) with use of electrolytes of a different composition to induce development of a homogeneous TiO2 layer on its surface. In vitro interactions of human osteoblast-like cell line Saos-2 with the surface of Ti-6Al-4V ELI alloy samples are investigated. Initial cell attachment, spreading, morphology, cell population density, viability, calcium deposition and expression of selected osteogenic markers, e.g. collagen type I, alkaline phosphatase and osteocalcin, were evaluated on cultured cells. The cells behavior were then correlated with physicochemical properties of the material surface, such as its topography, roughness, wettability, surface layer chemical composition etc. The results are also compared with those obtained in cells cultured on control samples of untreated alloys as well as microscopic glass coverslips and bottom of standard polystyrene cell culture wells. The aim of this thesis is to select the most promising...

No description available.

Der hierarchisch strukturierte und hoch geordnete Aufbau von Calciumphosphat und Kollagen in Knochen und Zähnen wird von den Zellen mit Hilfe bestimmter Moleküle erreicht. Diese organischen Moleküle, zumeist Proteine, beeinflussen durch die räumliche Anordnung ihrer Ladung das Präzipitations- und Wachstumsverhalten der mineralischen Phase. Die in dieser Arbeit beschriebenen Computersimulationen zeigen, dass ein Calciumphosphatkomplex mit deprotoniertem Phosphat am stabilsten ist. Vermutlich nimmt die Bindungsenergie pro Oberfläche des Komplexes mit wachsender Größe bis zu einem Ca9(PO4)6 -Komplex (Posner Klaster) linear zu. Die Präzipitation von Calciumphosphat aus wässriger Lösung führt häufig zu amorphen Kugeln mit 50-500 nm Durchmesser, die sphärische Unterstrukturen von ca. 5 nm Durchmesser zeigen und bei großer Dichte zu einer amorphen Schicht verschmelzen. Geringe Unterschiede in der Präparation können aber schon zu stäbchenförmigen oder plättchenartigen Kristalliten führen. Phosphoserin ist eine der wichtigsten Aminosäuren bei der Anbindung von Proteinen an Calciumphosphat. Das Computermodell zeigt an der gesamten Oberfläche dieser Aminosäure ein deutliches elektrisches Potential, dies begünstigt die Wechselwirkung mit Ionen. FT-IR- und NMR-Untersuchungen zeigen, dass Phosphoserin bei Kopräzipitation mit Calciumphosphat höchstwahrscheinlich in die mineralische Phase eingebaut wird. Serin zeigt bei der Kopräzipitation ab 1 mM einen Einfluss auf die Morphologie von Calciumphosphat, während Phosphoserin schon bei 0,01 mM einen deutlichen Einfluss zeigt. Elektronenspray-Ionisations-Massenspektroskopie (ESI-MS) bestätigt die relativ zum Serin intensivere Wechselwirkung von Phosphoserin mit Calciumphosphat. Das wichtigste Protein zur Vermeidung ektopischer Mineralisierung ist Fetuin. Dieses Protein stabilisiert die transient auftretenden amorphen Calciumphosphatkugeln (ACP-Kugeln) und erlaubt so dem Körper deren Entsorgung. Fetuin verhindert das Verschmelzen von ACP-Kugeln, wenn diese in großer Dichte auftreten, wobei deren feine Unterstruktur erhalten bleibt. Trotz des starken inhibitorischen Verhaltens wird das Auflösen von Brushit durch die Anwesenheit von Fetuin praktisch nicht beschleunigt. Auch auf die Kinetik der Assemblierung von Kollagen zeigt Fetuin praktisch keinen Einfluss. Des Weiteren wurde das Nukleationsverhalten des häufigsten, nichtkollagenen Knochenproteins, dem Osteocalcin (OC), mittels ESI-MS beobachtet. Die Untersuchungen von Osteocalcin in Calciumphosphatlösung zeigten Komplexe mit bis zu 8 Ca2+, der größte identifizierbare Komplex bestand aus [OC Ca2 (PO4 )2 Na4 ]+. Um die Mineralisierung von Kollagen genauer zu untersuchen, wurden assemblierte Kollagenfibrillen in der Flüssigzelle eines Atomkraftmikroskops (AFM) mit Calciumphosphat nachmineralisiert. Hierbei wurde eine gleichmäßige Anlagerung der offenbar amorphen mineralischen Phase beobachtet. Die Inkubation der Fibrillen mit Phospholipidvesikeln führte zu einem Aufweichen der Fibrillen. Des Weiteren wurden Phospholipidvesikel hergestellt, um den Calciumphosphatniederschlag in einem räumlich stark begrenzten Abschnitt zu untersuchen. Die Vesikel wurden mit REM und AFM abgebildet und so verschiedene Präparationsmethoden verglichen. Es konnten plättchenförmige Kristallite an der Vesikelmembran gezüchtet werden, während bei Anwesenheit von Phosphoserin globuläre Objekte auftraten. Eine Arbeitshypothese wurde entwickelt, die das unterschiedliche Wachstumsverhalten von Calciumphosphat in wässriger Lösung mit einer positiv geladenen Hydrathülle um den Calciumphosphatkeim erklärt. Die Protonen stammen vom deprotonierten Phosphat des Mineralkeims und können sich auf Grund der adsorbierten Wassermoleküle nicht sofort in der Lösung verteilen. Diese Hülle aus H3O+ verhindert das beliebige Anlagern von Ionen an den Mineralkeim und lenkt so dessen Morphologie.

Der hierarchisch strukturierte und hoch geordnete Aufbau von Calciumphosphat und Kollagen in Knochen und Zähnen wird von den Zellen mit Hilfe bestimmter Moleküle erreicht. Diese organischen Moleküle, zumeist Proteine, beeinflussen durch die räumliche Anordnung ihrer Ladung das Präzipitations- und Wachstumsverhalten der mineralischen Phase. Die in dieser Arbeit beschriebenen Computersimulationen zeigen, dass ein Calciumphosphatkomplex mit deprotoniertem Phosphat am stabilsten ist. Vermutlich nimmt die Bindungsenergie pro Oberfläche des Komplexes mit wachsender Größe bis zu einem Ca9(PO4)6 -Komplex (Posner Klaster) linear zu. Die Präzipitation von Calciumphosphat aus wässriger Lösung führt häufig zu amorphen Kugeln mit 50-500 nm Durchmesser, die sphärische Unterstrukturen von ca. 5 nm Durchmesser zeigen und bei großer Dichte zu einer amorphen Schicht verschmelzen. Geringe Unterschiede in der Präparation können aber schon zu stäbchenförmigen oder plättchenartigen Kristalliten führen. Phosphoserin ist eine der wichtigsten Aminosäuren bei der Anbindung von Proteinen an Calciumphosphat. Das Computermodell zeigt an der gesamten Oberfläche dieser Aminosäure ein deutliches elektrisches Potential, dies begünstigt die Wechselwirkung mit Ionen. FT-IR- und NMR-Untersuchungen zeigen, dass Phosphoserin bei Kopräzipitation mit Calciumphosphat höchstwahrscheinlich in die mineralische Phase eingebaut wird. Serin zeigt bei der Kopräzipitation ab 1 mM einen Einfluss auf die Morphologie von Calciumphosphat, während Phosphoserin schon bei 0,01 mM einen deutlichen Einfluss zeigt. Elektronenspray-Ionisations-Massenspektroskopie (ESI-MS) bestätigt die relativ zum Serin intensivere Wechselwirkung von Phosphoserin mit Calciumphosphat. Das wichtigste Protein zur Vermeidung ektopischer Mineralisierung ist Fetuin. Dieses Protein stabilisiert die transient auftretenden amorphen Calciumphosphatkugeln (ACP-Kugeln) und erlaubt so dem Körper deren Entsorgung. Fetuin verhindert das Verschmelzen von ACP-Kugeln, wenn diese in großer Dichte auftreten, wobei deren feine Unterstruktur erhalten bleibt. Trotz des starken inhibitorischen Verhaltens wird das Auflösen von Brushit durch die Anwesenheit von Fetuin praktisch nicht beschleunigt. Auch auf die Kinetik der Assemblierung von Kollagen zeigt Fetuin praktisch keinen Einfluss. Des Weiteren wurde das Nukleationsverhalten des häufigsten, nichtkollagenen Knochenproteins, dem Osteocalcin (OC), mittels ESI-MS beobachtet. Die Untersuchungen von Osteocalcin in Calciumphosphatlösung zeigten Komplexe mit bis zu 8 Ca2+, der größte identifizierbare Komplex bestand aus [OC Ca2 (PO4 )2 Na4 ]+. Um die Mineralisierung von Kollagen genauer zu untersuchen, wurden assemblierte Kollagenfibrillen in der Flüssigzelle eines Atomkraftmikroskops (AFM) mit Calciumphosphat nachmineralisiert. Hierbei wurde eine gleichmäßige Anlagerung der offenbar amorphen mineralischen Phase beobachtet. Die Inkubation der Fibrillen mit Phospholipidvesikeln führte zu einem Aufweichen der Fibrillen. Des Weiteren wurden Phospholipidvesikel hergestellt, um den Calciumphosphatniederschlag in einem räumlich stark begrenzten Abschnitt zu untersuchen. Die Vesikel wurden mit REM und AFM abgebildet und so verschiedene Präparationsmethoden verglichen. Es konnten plättchenförmige Kristallite an der Vesikelmembran gezüchtet werden, während bei Anwesenheit von Phosphoserin globuläre Objekte auftraten. Eine Arbeitshypothese wurde entwickelt, die das unterschiedliche Wachstumsverhalten von Calciumphosphat in wässriger Lösung mit einer positiv geladenen Hydrathülle um den Calciumphosphatkeim erklärt. Die Protonen stammen vom deprotonierten Phosphat des Mineralkeims und können sich auf Grund der adsorbierten Wassermoleküle nicht sofort in der Lösung verteilen. Diese Hülle aus H3O+ verhindert das beliebige Anlagern von Ionen an den Mineralkeim und lenkt so dessen Morphologie.:1 Einführung 1.1 Biomineralisation 1.2 Calciumphosphat 1.3 Phosphoserin 1.4 Kollagen 1.5 Osteocalcin 1.6 Fetuin 1.7 Matrixvesikel 1.8 Fragestellung der Dissertation 2 Material und Methoden 2.1 Computermodellierung 2.2 Chemikalien und Lösungen 2.3 FT-IR-Messungen 2.4 UV/Vis-Messungen 2.5 Massenspektroskopische Experimente 2.6 REM 2.7 TEM 2.8 AFM 2.9 NMR 2.10 XRD 3 Ergebnisse und Interpretation 3.1 Calciumphosphat 3.2 Phosphoserin 3.3 Fetuin 3.4 Osteocalcin 3.5 Kollagen 3.6 Künstliche Vesikel 4 Abschließende Zusammenfassung Anhang Erläuterungen zu den Ergebnissen Glossar Abbildungsverzeichnis Tabellenverzeichnis Literaturverzeichnis Erklärung, Danke Publikationen Lebenslauf Index